BB Biotech AG Total Liabilities is NA for the year ending August 20, 2025. Total liabilities are the total amount of a company's debts and other obligations.

Competitors

Eli Lilly and Company

USD 703.21

LLY

+5.16 0.74%

AbbVie Inc.

USD 206.19

ABBV

-0.38 -0.18%

Roche Holding AG

USD 337.32

RO.SW

+4.54 1.36%

Novo Nordisk A/S

USD 54.16

NOVO-B.CO

-0.02 -0.03%

Novartis AG

USD 124.85

NOVN.SW

+0.78 0.63%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Merck & Co., Inc.

USD 84.93

MRK

+0.71 0.84%

Thermo Fisher Scientific Inc.

USD 498.29

TMO

+10.75 2.21%

Amgen Inc.

USD 295.55

AMGN

+2.93 1.00%

Boston Scientific Corporation

USD 103.75

BSX

+0.70 0.68%

Gilead Sciences, Inc.

USD 117.98

GILD

-0.01 -0.01%

Pfizer Inc.

USD 25.32

PFE

+0.25 1.00%

Sanofi

USD 100.73

SAN.PA

+0.93 0.94%

Vertex Pharmaceuticals Incorporated

USD 390.76

VRTX

+0.88 0.23%

Bristol-Myers Squibb Company

USD 48.34

BMY

+0.15 0.31%

View all

Key Data

Date	Total Liabilities	Shareholders' Equity	Cash and Short-Term Investments	Receivables